Display options
Share it on

Eur J Cancer Clin Oncol. 1988 Feb;24(2):345-50. doi: 10.1016/0277-5379(88)90278-7.

Follow-up of patients with differentiated thyroid carcinoma. Experience at Institut Gustave-Roussy, Villejuif.

European journal of cancer & clinical oncology

M Schlumberger, J P Travagli, P Fragu, P Gardet, J Lumbroso, C Parmentier

Affiliations

  1. Institut Gustave-Roussy, Villejuif, France.

PMID: 3356217 DOI: 10.1016/0277-5379(88)90278-7

Abstract

The recent introduction of sTSH assays allows for a definite control of the inhibition of TSH secretion. Clinical examination and serum thyroid hormone measurements are necessary to obviate hyperthyroidism. Relapses may occur after decades of apparent complete remission. Follow-up should be pursued throughout the patient's lifetime. Two specific means allow the detection of relapses at a stage when X-rays are still normal: measurement of serum thyroglobulin and 131I total body scan. Their combined use is recommended.

Cited by

Substances

MeSH terms

Publication Types

LinkOut - more resources